Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver

NCT03005002 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Carcinoma in the Liver
MLH1 Gene Mutation
MSH6 Gene Mutation
PMS2 Gene Mutation
Stage IV Colorectal Cancer
Stage IVA Colorectal Cancer
Stage IVB Colorectal Cancer

Interventions

BIOLOGICAL: Durvalumab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Tremelimumab

Sponsor

City of Hope Medical Center

Collaborators

[object Object]